Literature DB >> 10464006

PTP1B inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-arylbenzo[b]naphtho[2,3-d]furans and 11-arylbenzo[b]naphtho[2,3-d]thiophenes.

J Wrobel1, J Sredy, C Moxham, A Dietrich, Z Li, D R Sawicki, L Seestaller, L Wu, A Katz, D Sullivan, C Tio, Z Y Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10464006     DOI： 10.1021/jm990260v

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  12 in total

1.  Structure-based prediction of free energy changes of binding of PTP1B inhibitors.

Authors:  Jing Wang; Shek Ling Chan; Kal Ramnarayan
Journal:  J Comput Aided Mol Des       Date:  2003-08       Impact factor: 3.686

2.  PTP1B inhibitor improves both insulin resistance and lipid abnormalities in vivo and in vitro.

Authors:  Yi-ming Ma; Rong-ya Tao; Qian Liu; Juan Li; Jin-ying Tian; Xiao-lin Zhang; Zhi-yan Xiao; Fei Ye
Journal:  Mol Cell Biochem       Date:  2011-05-21       Impact factor: 3.396

Review 3.  Targeting Tyrosine Phosphatases: Time to End the Stigma.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Trends Pharmacol Sci       Date:  2017-04-12       Impact factor: 14.819

Review 4.  New pharmacologic agents for diabetes.

Authors:  C J Bailey
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

5.  Molecular dynamics simulation study of PTP1B with allosteric inhibitor and its application in receptor based pharmacophore modeling.

Authors:  Kavitha Bharatham; Nagakumar Bharatham; Yong Jung Kwon; Keun Woo Lee
Journal:  J Comput Aided Mol Des       Date:  2008-08-07       Impact factor: 3.686

Review 6.  Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.

Authors:  Amy K Rines; Kfir Sharabi; Clint D J Tavares; Pere Puigserver
Journal:  Nat Rev Drug Discov       Date:  2016-08-12       Impact factor: 84.694

7.  QSAR studies of benzofuran/benzothiophene biphenyl derivatives as inhibitors of PTPase-1B.

Authors:  D Kaushik; R Kumar; A K Saxena
Journal:  J Pharm Bioallied Sci       Date:  2010-01

8.  The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.

Authors:  Emmanuel Tadjuidje; Tim Sen Wang; Ram Naresh Pandey; Saulius Sumanas; Richard A Lang; Rashmi S Hegde
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

Review 9.  Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma.

Authors:  Mariana Tannús Ruckert; Pamela Viani de Andrade; Verena Silva Santos; Vanessa Silva Silveira
Journal:  Cell Mol Life Sci       Date:  2019-04-13       Impact factor: 9.207

10.  Structure-activity relationships of benzbromarone metabolites and derivatives as EYA inhibitory anti-angiogenic agents.

Authors:  Ram Naresh Pandey; Tim Sen Wang; Emmanuel Tadjuidje; Matthew G McDonald; Allan E Rettie; Rashmi S Hegde
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.